A
AGMB//CIK 0002020932
Agomab Therapeutics NV
Market Data
$10.77−$2.48 (−18.75%)
AGMB · Last trade
Prev Close
$13.25
Range (30d)
$10.77 – $15.78
Recent Filings
- 6-K38.7 KBAgomab Therapeutics NVSep 14, 4:14 PM ET·0001104659-26-107500
- 6-K29.0 KBAgomab Therapeutics NVSep 11, 5:02 PM ET·0001104659-26-107117
- 6-K5.4 MBAgomab Therapeutics NVAug 10, 4:17 PM ET·0001104659-26-093390
- 6-K260.5 KBAgomab Therapeutics NVAug 6, 4:06 PM ET·0001104659-26-091992
- 6-K60.8 KBAgomab Therapeutics NVJun 23, 4:13 PM ET·0001104659-26-076819
- 6-K37.3 KBAgomab Therapeutics NVMay 27, 7:12 AM ET·0001104659-26-066590
- 6-K2.9 MBAgomab Therapeutics NVApr 24, 4:22 PM ET·0001104659-26-048615
- 6-K130.5 KBAgomab Therapeutics NVMar 5, 4:05 PM ET·0001104659-26-024095
- 6-K177.9 KBAgomab Therapeutics NVFeb 9, 4:18 PM ET·0001104659-26-012080
Insiders
10- Bond Colin MichaelDirector
- Borderias Andrea SaezChief Development Officer
- Epstein David RDirector
- Garcia MarinoDirector
- Hammer OhadDirector
- Jahreis Angelika MarthaDirector
- Kemula Pierre Thadee VictorChief Financial Officer
- Knotnerus Tim JasperDirector, Chief Executive Officer
- Lefever EllenGeneral Counsel
- Patel NaimishDirector
Tickers
Addresses
business
POSTHOFLEI 1/6
ANTWERPEN, 2600
mailing
POSTHOFLEI 1/6
ANTWERPEN, 2600